Cyclopharm Limited (CYC.AX)
ASX · AUD · Healthcare · Medical Devices
A$0.37 (-1.33%) as of
Key statistics
- Market cap
- 46.52M
- Forward P/E
- -4.12
- EPS (TTM)
- -0.1500
- Dividend yield
- 0.00%
- 52-week range
- 0.3300 – 1.2900
- Beta
- 0.64
- Revenue (TTM)
- 34.42M
- Profit margin
- -53.23%
- Analyst target
- A$1.02
- Volume
- 2.41k
About Cyclopharm Limited
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Kingsgrove, NSW, Australia
- Employees
- 104
cyclomedica.com/company/cyclopharm/
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.